| 0.57 Data as of May 17 |  -0.02 / -3.39%Today’s Change | 0.52 Today|||52-Week Range 2.35 | -54.76% Year-to-Date |
| Previous close | 0.59 |
| Today’s open | 0.59 |
| Day’s range | 0.57 - 0.60 |
| Volume | 177,156 |
| Average volume (3 months) | 472,991 |
| Market cap | $26.0M |
| Dividend yield | -- |
| Earnings growth (last year) | -58.82% |
| Earnings growth (this year) | +37.58% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +16.67% |
| P/E ratio | NM |
| Price/Sales | 2,471.94 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| CRMECardiome Pharma Corp | +0.03 | +1.42% |
| ELTPElite Pharmaceutical... | 0.00 | 0.00% |
| PRPHProPhase Labs Inc | +0.01 | +0.86% |
| PTNPalatin Technologies... | +0.02 | +3.23% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $21.0K |
| Annual profit (last year) | -$29.5M |
| Net profit margin | -140,352.38% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Dominick C. Colangelo |
Secretary, Treasurer, CAO & VP-Finance Brian D. Gibson, CPA |
Corporate headquarters Ann Arbor, Michigan |
.
